Introduction
As many as 7% of childbearing-age women in the United States have chronic hypertension. 1 With the increasing rates of obesity, trend toward delayed childbearing, and appreciation for maternal cardiovascular disease as a major contributor to maternal mortality, the effects of hypertension on pregnancy are of relevant concern.
2,3 Adverse perinatal outcomes associated with chronic hypertension are known to include placental abruption, superimposed preeclampsia, and stroke. 4 The American Congress of Obstetricians and Gynecologists convened the 2013 Hypertension in Pregnancy Task Force to address the perinatal concerns associated with chronic hypertension. 5 The task force recommended establishment of baseline function of organs that are known to be compromised as a result of longstanding chronic hypertension. Pursuant to this objective, our group investigated the impact of chronic hypertension on both the heart and kidney and its association with adverse perinatal outcomes. 6, 7 In women with abnormal baseline proteinuria and those with left ventricular (LV) hypertrophy, we reported that there were increased risks for superimposed preeclampsia and preterm delivery with subsequent need for neonatal intensive care.
The American Society of Echocardiography (ASE) has recently updated its guidelines to better characterize cardiac remodeling as ascertained by echocardiography. 8 These guidelines include a measurement of both LV mass index (g/m 2 ) and relative wall thickness calculated as (2 Â posterior wall thickness)/(LV internal diameter at end diastole) to define cardiac remodeling as normal, concentric remodeling, eccentric hypertrophy, or concentric hypertrophy. 8 While there is considerable literature on both physiologic and pathologic cardiac remodeling, little is known about the effects of abnormal cardiac remodeling on pregnancy. 
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Physiologic remodeling is considered to be an adaptive process occurring through sustained increased stroke volume such as exercise or pregnancy with hypertrophy of cardiomyocytes receiving a normal blood supply. Pathologic remodeling is caused by an insult such as long-standing chronic hypertension or a myocardial infarction with hypoxia, which ultimately leads to fibrosis.
9,10
Using these updated definitions, the current study classifies a cohort of treated chronically hypertensive pregnant women into 4 categories and assesses perinatal outcomes based on this classification.
Materials and Methods
This retrospective study included women with chronic hypertension treated during pregnancy and cared for at Parkland Hospital from January 2009 through January 2016. The Dallas County Hospital District operates the hospital and it serves the medically indigent of Dallas County, Texas. These women are cared for in a dedicated high-risk prenatal clinic staffed by maternal-fetal medicine faculty, fellows, and residents. Some women entered care while receiving antihypertensive medication because of a preexisting diagnosis of chronic hypertension defined as systolic blood pressure !140 mm Hg or diastolic blood pressure !90 mm Hg. Other women included in the study were diagnosed during early pregnancy based on persistent readings of systolic pressures >150 mm Hg or diastolic pressures >100 mm Hg. 7 Over the years of the study, these women were treated with an a-adrenergic agonist (methyldopa), a combined a-b blocker (labetalol), a calcium-channel blocker (amlodipine), or a combination thereof. Women who entered care taking these antihypertensive medication(s) were continued on the same medication if they were well controlled. Those on antihypertensive medications not safe in pregnancy (eg, angiotensin-converting enzyme inhibitors) were transitioned to these medications. Antihypertensive medications were titrated to achieve blood pressures of <150 mm Hg systolic and <100 mm Hg diastolic. 5 The institutional review boards of University of Texas Southwestern Medical Center and Parkland Hospital approved this study.
At the time of their first prenatal visit, these women undergo detailed evaluation for end-organ effects as well as routine prenatal testing. The previously described evaluation includes measurement of voided urine protein, a 24-hour urine collection for protein quantification to assess baseline protein excretion, and a scheduled outpatient maternal echocardiogram for assessment of cardiac function and structure. 6, 7 Echocardiography is accomplished using a transthoracic 2-dimensional machine (EPIQ 7c, Philips, Andover, MD) performed by certified technicians and supervised by a faculty cardiologist from University of Texas Southwestern Medical Center. Measurements of cardiac parameters of interest for this analysis included LV mass, systolic ejection fraction, LV posterior wall thickness at end diastole, LV internal diameter at end diastole, and body surface area. In accordance with the recently published guidelines from ASE, cardiac geometry was defined and categorized based on the presence of increased indexed LV mass and relative wall thickness. 8 
AJOG at a Glance
Why was this study conducted? Recent definitions of maternal cardiac remodeling using echocardiography in pregnant women with treated chronic hypertension elucidated perinatal outcomes based on these new strata.
Key findings Approximately half of women with treated chronic hypertension have evidence of abnormal cardiac remodeling as determined by echocardiography and remodeling was associated with adverse perinatal outcomes such as preterm delivery, superimposed preeclampsia, and intrauterine growth restriction despite a preserved ejection fraction.
What does this add to what is known?
Half of women with treated chronic hypertension in pregnancy have evidence of abnormal cardiac remodeling with increased perinatal risks despite a preserved ejection fraction.
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Superimposed preeclampsia was diagnosed clinically by acute blood pressure elevation, marked increase in proteinuria (!300 mg of protein within a 24-hour period), characteristic symptoms, and/or laboratory evidence indicative of severe disease including thrombocytopenia, elevated serum hepatic transaminase concentrations, or increased serum creatinine levels. Perinatal outcomes assessed included gestational age at delivery, preterm birth, superimposed preeclampsia, admission to the neonatal intensive care unit, birthweight, ventilator use within 24 hours, abruption, and stillbirth.
Univariate analyses were performed using Pearson c 2 , Fisher exact, independent-group Student t tests, Dunnett test, and analysis of variance. Adjusted analyses using logistic regression were performed for maternal age, race, parity, and habitus. Results were considered significant if P < .05.
Results
During the 7-year study, a total of 314 women with treated chronic hypertension underwent echocardiography.
There were 159 women (51%) with evidence of abnormal cardiac remodeling defined as concentric remodeling, eccentric hypertrophy, or concentric hypertrophy. Maternal demographics stratified by the subtype of cardiac remodeling are shown in Table 1 . There were differences in race among the groups, with black women more likely to have concentric hypertrophy and Hispanic women more likely to have evidence of concentric remodeling and eccentric hypertrophy (P < .001). There were no other demographic differences among the groups. For the entire study cohort, obesity was prevalent with 83% of women having a body mass index (kg/ m 2 ) >30 kg/m 2 and 32% of women with a body mass index >40 kg/m 2 . The characteristics of chronic hypertension for the study cohort are shown in Table 2 . The duration of diagnosis of chronic hypertension did not differ among the 4 groups (P ¼ .212). Blood pressure profiles at initial presentation were elevated for the entire cohort pursuant with the diagnosis of chronic hypertension, and these profiles corresponded to the need for !1 antihypertensive agents ( Table 2 ). All women in this analysis received antihypertensive therapy during pregnancy with 26% of the cohort already prescribed antihypertensive therapy prior to their initial visit ( Table 2) . Rates of medication use prior to pregnancy were not different among the 4 groups (P ¼ .24). Overall, approximately 12% of women required !2 medications in the management of hypertension ( Table 2 ). There were no differences in gestational diabetes among the 4 groups (P ¼ .059).
Shown in Table 3 are measurements from the maternal echocardiogram studies. The echocardiograms were performed at a mean gestational age of 17.9 weeks and gestational age at which the exam was performed was not different among the 4 groups (P ¼ .838). As expected because of the categories, there were significant differences between LV mass (P ¼ .001) and relative wall thickness (P ¼ .001) among the groups. Interventricular septal diameter was also significantly different among the groups with larger measurements in those with abnormal remodeling (P ¼ .001). Interestingly, ejection fraction as measured by method of discs, 4 plane was preserved, but was statistically significantly different among the groups (P ¼ .02).
Selected perinatal outcomes are shown in Figure 3 and Table 4 . Overall, superimposed preeclampsia was common and was most frequent in those with eccentric hypertrophy (P ¼.015). In all 3 groups with abnormal remodeling, the risk of early preterm delivery ( 34 weeks) was also significantly increased compared with those women with normal geometry (P < .001). For the majority of these early births, superimposed preeclampsia was the indication for delivery. Concomitant with gestational age at delivery, neonatal intensive care admission and birthweight <2500 g were also significantly increased in the 3 groups with evidence of abnormal remodeling compared with women who had normal geometry: P ¼.003 and P <.001 respectively. When adjusted for age, race, parity, and maternal habitus, superimposed preeclampsia, early preterm delivery, and (Table 5 ). There was no difference in frequency of stillbirth (P ¼ .823) or neonatal death (P ¼ .302) among the 4 groups.
Comment
In this study of 314 treated chronically hypertensive pregnant women, we expand on our previous studies that concern baseline target organ effects caused by chronic hypertension and their association with adverse perinatal outcomes. There are at least 3 observations from the results of this analysis of maternal echocardiograms performed during the first half of pregnancy. First, approximately half (51%) of women with treated chronic hypertension during pregnancy had evidence for abnormal cardiac remodeling. Second, when compared with normal cardiac geometry, women with abnormal cardiac remodeling had significantly increased rates of superimposed preeclampsia, and consequently, increased rates of early preterm birth, admission to neonatal intensive care, and birthweight <2500 g. Third, the highest frequency of adverse perinatal outcomes was in the group with eccentric hypertrophy when compared with women with normal cardiac geometry. Taken together, women with chronic hypertension receiving treatment during pregnancy have substantial rates of adverse perinatal outcomes that can largely be attributed to the development of superimposed preeclampsia, and women with target-organ effects of the heart are of the highest risk for these complications.
Our first finding is that half of women in this cohort had evidence of abnormal cardiac remodeling. Because these echocardiograms were done at a median gestational age of 17.9 weeks, this may be associated with prepregnancy pathologic remodeling as a result of longstanding chronic hypertension rather than pregnancy-induced remodeling. It is well known that in nonpregnant subjects with long-standing hypertension, there are pathophysiologic cardiac effects that are associated with increased cardiovascular events and mortality. [11] [12] [13] While cardiac remodeling has been studied in pregnant women, there are only a few reports that describe the impact of preexisting hypertension to these ventricular geometric changes.
6,14-17 Indeed, these latter reports showed an excess of concentric and eccentric ventricular hypertrophy. The current study differs from these prior reports in that this cohort is of women with hypertension severe enough to require antihypertensive medications and that the updated definitions were applied to cardiac remodeling indexed to maternal body surface area. 8 The second finding was that women with abnormal cardiac remodeling had an excessive risk for adverse perinatal outcomes (Figure 3 and Tables 4 and 5 ). As shown in Table 5 , these risks persisted despite adjustment for pertinent maternal factors. This is not surprising because increasing pregnancy risks correlate with an increase in the end-organ manifestations of chronic hypertension. 4 We have previously identified that women with early baseline abnormal proteinuria or with LV hypertrophy have increased rates of superimposed preeclampsia and preterm birth. 6, 7 Our prior study did not take into account the 2015 ASE definitions of wall thickness, but showed that the presence of LV hypertrophy alone (14) 24 (24) 5 (23) 5 (13) 1 45 (29) 21 (21) 3 (14) 9 (23) (defined as LV mass index >95 g/m 2 ) was associated with these adverse perinatal outcomes. Likewise, Allen et al 18 recently described adverse outcomes associated with higher baseline blood pressures requiring >1 medication for control of hypertension. In sum, all of these studies attest to the importance of burden of disease on perinatal outcomes.
Thirdly, we found that adverse outcomes were significantly more common in women with eccentric ventricular hypertrophy when compared with those with normal geometry. There have been numerous studies in nonpregnant adults showing a pattern of eccentric hypertrophy with long-term endurance exercise in athletes as an adaptive mechanism with increased LV dimensions. [19] [20] [21] Quitete et al 22 observed that 65% of normotensive pregnant women and 68% of hypertensive pregnant women had evidence of eccentric (12) 7 (7) 1 (5) 3 (8) ajog.org
OBSTETRICS Original Research
hypertrophy >25th week of gestation, which was believed to be evidence of physiological remodeling due to pregnancy in both groups. We, as well as others, have described increasing LV mass during pregnancy with a return to normal 3 months postpartum, which represents normal adaptive changes to pregnancy-induced hypervolemia. 16, 23 However, in the currently described cohort of women with relatively longstanding hypertension requiring treatment, it is more likely these changes are baseline prepregnancy pathologic changes from the effects of chronic hypertension with implications not only for pregnancy, but for future maternal health.
This retrospective study has several limitations. First, it is a single-center trial of predominantly obese Hispanic and black women, which may not be generalizable to other populations. Second, we used the definitions from the ASE, which
are not yet validated in a pregnant population. 8 These indices are however, gender-specific for females and corrected for maternal body habitus. A third limitation is the lack of echocardiographic assessments prior to and later in pregnancy as well as remotely postpartum. Strengths of the study are in the enriched cohort of women followed up in a dedicated high-risk clinic with disease burden significant enough to require antihypertensive therapy. Upon entry into prenatal care at our institution all of these women with treated chronic hypertension had an echocardiogram ordered as part of their initial assessment. Finally, the odds ratios were calculated using the outcomes from the normal geometry group as the referent ( Table 5 ). We acknowledge that this group also has long-standing hypertension and that risks compared with those of normotensive women are substantially increased.
This study supports the notion that pregnancy is a window to future maternal health. The American Heart Association recognizes hypertension as a leading concern in women's health and the increased risk for developing cardiovascular disease and stroke after a pregnancy affected by hypertension. 24 Moreover, there are also data showing that ventricular hypertrophy is a marker for long-term mortality and cardiovascular events. 9 These findings are especially relevant given the recently reported increased rates of maternal mortality in the United States. 25 Indeed, the contribution of cardiovascular conditions has been implicated in these recent increases of pregnancy-related mortality. 2 Our study identifies a group of at-risk women who have baseline end-organ pathophysiology assessed in the first half of pregnancy. The importance of abnormal cardiac remodeling on perinatal outcomes is evidenced by the overall high frequency of adverse outcomes ( Figure 3 ). When evaluating evidence of cardiac end-organ damage in chronically hypertensive women, it is important to remember that while ejection fraction is usually preserved, there may still be evidence of disease burden in other parameters such as those we have described. It remains unknown if these women have further abnormal remodeling during pregnancy and, if so, if it regresses postpartum. Moreover, it is unknown if the additional normal pregnancy remodeling in hypertensive women has permanent adverse sequelae. Selected perinatal outcomes associated with abnormal cardiac remodeling Perinatal outcomes. 
